NovaBridge Biosciences (NBP) Current Taxes (2022)
NovaBridge Biosciences (NBP) posted quarterly Current Taxes of $9.1 million for Q4 2022, up 596.91% on a QoQ basis from $1.3 million in Q2 2022.
NovaBridge Biosciences (NBP) Current Taxes (2022) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Current Taxes for 1 consecutive years, with $9.1 million the latest figure, recorded in Q4 2022.
- Quarterly Current Taxes changed N/A year-over-year to $9.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $9.1 million (changed N/A YoY) and the FY2022 annual result came in at $9.4 million, changed N/A from the prior year.
- Current Taxes rose to $9.1 million in Q4 2022 per NBP's latest filing, from $1.3 million in the prior quarter.
- Over the last five years, Current Taxes for NBP reached as high as $9.1 million in Q4 2022 and fell as low as $1.3 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 9.11 Mn |
| Jun 30, 2022 | 1.31 Mn |